Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2314337121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Nan Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Alzheimer Disease, Colorectal Neoplasms, Fecal Microbiota Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Hebei Natural Science Foundation, Funding project for introducing overseas students of Hebei Province.
Themen: Demenz
Abstract (Originalsprache)
Epidemiological studies have revealed an inverse relationship between the incidence of Alzheimer’s disease (AD) and various cancers, including colorectal cancer (CRC). We aimed to determine whether the incidence of CRC is reduced in AD-like mice and whether gut microbiota confers resistance to tumorigenesis through inducing inflammatory tolerance using 16S ribosomal RNA gene sequencing and fecal microbiota transplantation (FMT). AD-like mice experienced a significantly decreased incidence of CRC tumorigenesis induced by azoxymethane–dextran sodium sulfate as evidenced by suppressed intestinal inflammation compared with control mice. However, FMT from age-matched control mice reversed the inhibitory effects on the tumorigenesis of CRC and inflammatory response in AD-like mice. The key bacterial genera in gut microbiota, including Prevotella , were increased in both the AD-like mice and in patients with amnestic mild cognitive impairment (aMCI) but were decreased in patients with CRC. Pretreatment with low-dose Prevotella -derived lipopolysaccharides (LPS) induced inflammatory tolerance both in vivo and in vitro and inhibited CRC tumorigenesis in mice. Imbalanced gut microbiota increased intestinal barrier permeability, which facilitated LPS absorption from the gut into the blood, causing cognitive decline in AD-like mice and patients with aMCI. These data reveal that intestinal Prevotella -derived LPS exerts a resistant effect to CRC tumorigenesis via inducing inflammatory tolerance in the presence of AD. These findings provide biological evidence demonstrating the inverse relationship between the incidence of AD and CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People's Republic of China.
- Hebei International Joint Research Center for Brain Science, Shijiazhuang 050031, People's Republic of China.
- Hebei Key Laboratory of Brain Science and Psychiatric-Psychologic Disease, Shijiazhuang 050031, People's Republic of China.
- Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, Chinese Academy of Medical Sciences, Beijing 100730, People's Republic of China.
ORCID-Profile: Nan Zhang, Lei Jiang, Zhaoyu Gao
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Hebei Natural Science Foundation
- Funding project for introducing overseas students of Hebei Province
- Medical Science Research Project of Hebei Province
- Hebei Province Government-funded Excellent Talents Project in Clinical Medicine
- The Science and Technology project of the People's Livelihood in Hebei Province
- Special Funding for Local Science and Technology Development Guided by the Central Government
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Zhang, N., Zhang, R., Jiang, L., Gao, Z., Xia, W., Ma, X., Qin, Y., Zhang, D., Li, J., Tian, P., Zhang, Q., Wang, W., Zhang, K., Xu, S., Zhao, N., & Xu, S. (2024). Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2314337121
Vancouver
Zhang N, Zhang R, Jiang L, Gao Z, Xia W, Ma X, et al. Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2314337121
BibTeX
@article{Zhang2024,
author = {Zhang, Nan and Zhang, Rui and Jiang, Lei and Gao, Zhaoyu and Xia, Wenzhen and Ma, Xiaoying and Qin, Yushi and Zhang, Di and Li, Jiazheng and Tian, Pei and Zhang, Qi and Wang, Wanchang and Zhang, Kaixia and Xu, Shan and Zhao, Na and Xu, Shunjiang},
title = {Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2314337121}
}
EUVIMED